David P. Schenkein

2013

In 2013, David P. Schenkein earned a total compensation of $1.6M as President and Chief Executive Officer at Agios Pharmaceuticals, a 128% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$204,000
Option Awards$957,057
Salary$425,000
Other$3,005
Total$1,589,062

Schenkein received $957.1K in option awards, accounting for 60% of the total pay in 2013.

Schenkein also received $204K in non-equity incentive plan, $425K in salary and $3K in other compensation.

Rankings

In 2013, David P. Schenkein's compensation ranked 4,709th out of 12,286 executives tracked by ExecPay. In other words, Schenkein earned more than 61.7% of executives.

ClassificationRankingPercentile
All
4,709
out of 12,286
62nd
Division
Manufacturing
1,615
out of 4,614
65th
Major group
Chemicals And Allied Products
468
out of 1,466
68th
Industry group
Drugs
328
out of 1,160
72nd
Industry
Pharmaceutical Preparations
262
out of 890
71st
Source: SEC filing on April 27, 2016.

Schenkein's colleagues

We found three more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2013.

2013

Glenn Goddard

Agios Pharmaceuticals

Sr. Vice President, Finance

2013

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2013

J Higgons

Agios Pharmaceuticals

Chief Operating Officer

News

In-depth

You may also like